logo
The Biggest Broccoli Recalls In History

The Biggest Broccoli Recalls In History

Yahoo15-02-2025
Broccoli is a versatile vegetable that can be used in everything from a delicious stir-fry to a creamy soup. This crunchy, crisp cruciferous veggie is jam-packed with vitamins, minerals, and other nutrients that make it a conscious addition to many meals. From adding it to your breakfast in an omelet to pairing it with your favorite protein as a side for dinner, the options for incorporating more broccoli into your diet truly are endless.
But unfortunately, this beloved type of produce is also susceptible to contamination with a bacteria that causes food-borne illness: Listeria monocytogenes. Over the years, exposure to this nasty bug has polluted multiple different broccoli products, resulting in everything from small, voluntary recalls to country-wide Class I recalls initiated by the U.S. Food and Drug Administration (FDA).
We take a look at some of the biggest broccoli recalls in history and discover what steps were taken to prevent any disastrous outcomes as a result of the contamination.
Read more: 11 Store-Bought Italian Dressing Brands, Ranked Worst To Best
In late December 2024, Braga Fresh — a California-based shipper and retailer of fresh veggies and salads — issued a precautionary advisory for their Marketside Broccoli Florets. The advisory was for just one production lot of the washed and ready-to-eat packaged broccoli, and only for packages with a "best if used by date" of December 10, 2024.
Braga Fresh issued the advisory after the company learned the broccoli had been potentially contaminated with Listeria monocytogenes. This bacteria can cause a myriad of symptoms ranging from fever and aches to intestinal upset. Contaminated packages potentially tainted by the bacteria were sold at Walmart locations in 20 states across the country, including Oregon, Washington, and California.
After the initial precautionary advisory was issued, the Food and Drug Administration issued an official recall in December 2024, and then took it a step further by upgrading the recall to a Class 1 in January 2025. This type of recall signifies that there is "a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death." Though no illnesses had been reported as of early February 2025, consumers were advised to immediately discard or return any potentially contaminated broccoli to avoid extreme consequences.
Trader Joe's is beloved by its dedicated shoppers for its delicious ready-made meals that are fast, easy, and nutritious. But one of these fan-favorite products posed a potential health risk to consumers in the summer of 2023 (and was only one of several recalls on TJ's cult favorites).
The grocery chain issued a voluntary recall of its Unexpected Broccoli Cheddar Soup on July 27, 2023, after one of its suppliers — Winter Gardens Quality Foods, Inc. — discovered the broccoli in the soup may contain insects. The voluntary recall affected 10,889 cases of soup with 12 of the 20-ounce containers per case; that's a whopping 130,668 containers.
The recall impacted Trader Joe's locations in seven states — Florida, Illinois, California, Texas, Washington, Pennsylvania, and Connecticut — and soup with use-by dates between July 18 and September 15, 2023.Though no one got sick from the contaminated soup, Trader Joe's recommended that all containers from the identified lots be discarded immediately to be on the safe side.
Imagine taking a bite of your favorite beloved broccoli tots, only to crunch down on small rocks or metal fragments. This unlikely scenario became a reality for two consumers in August 2022 when they discovered small rocks and metal fragments in their Birds Eye Broccoli Tots, leading to dental damage.
The company issued a recall of four lots of this delicious broccoli snack with a mix of best-by dates in August and November of the same year. After the voluntary recall, stores removed all of the potentially harmful 12-ounce packages from their shelves, and the FDA recommended consumers do the same.
Made from a mix of broccoli, cauliflower, potatoes, onions, and different spices and binders, it wasn't identified which ingredient specifically was the possible culprit in these frozen morsels. But given that the broccoli tots are no longer listed on the Birds Eye website and are out of stock at many online retailers, it seems that the recall may have had a lasting impact.
In spring 2020, inspectors from the Connecticut Department of Consumer Protection raised the alarm after finding Listeria monocytogenes in Stop & Shop's Private Brand Frozen Broccoli Cuts.
This harmful bacteria leads to listerosis, a food-borne illness that leads to fever, chills, and headache. It's especially risky in pregnant people, the elderly, and those with weakened immune systems, making any potential contamination extremely high risk.
Though the contaminated bag was found in South Windsor, Connecticut, the brand recalled broccoli from over 400 stores across four states — New Jersey, New York, Connecticut, and Massachusetts. The grocery giant asked that all consumers toss or return any bags of broccoli with a sell-by date of March 15, 2020 to avoid any food-borne diseases. Luckily, no illnesses were ever reported.
The grocery giant is no stranger to recalls. After the broccoli recall, Stop & Shop was also subject to recalls on cooked shrimp in 2021, breaded chicken cutlets in July 2024, and frozen waffles later the same year.
In late summer 2019, grocery chain Meijer announced a voluntary recall of two items: vegetable trays and broccoli used in their salad bars. The produce was potentially contaminated by the bacteria Listeria monocytogenes, known to cause sever gastrointestinal distress and nasty flu-like symptoms.
The vegetable tray recall impacted Meijer stores in six states across the midwest, and the salad bar broccoli recall was specifically for two stores in the Grand Rapids, Michigan region. Though no illnesses were reported, consumers were urged to return or throw out any items with sell-by dates in a specific date range from September to November 2019.
Several other recalls have also plagued the grocery chain over the years. This broccoli recall in 2019 was close on the heels of a similar Meijer fresh vegetable recall in fall 2017. The previous recall impacted not only the vegetable trays but also a range of produce including broccoli, cauliflower, squash, asparagus, and brussel sprouts.
In June 2016, Butterfield Foods was alerted to a major problem: the sunflower seeds used in their broccoli salad kit dressing was possibly contaminated with Listeria monocytogenes. The resulting recall impacted nearly 16,000 pounds of their broccoli salad kits from various dates between November of 2015 and May of 2016. No illnesses as a result of the contamination, however, were ever confirmed.
Based in Indiana, this private-label food production company makes a range of products that are then distributed to restaurants, grocery chains, and convenience stores. And despite their commitment to quality, they were also subject to a massive recall on nearly 300,000 pounds of barbecue beef, pork and chicken products in 2011 due to the possible presence of an unstated soy allergen prior to the broccoli salad kit recall in 2016. These two incidents, however, seem to be the only recalls on Butterfield Foods' otherwise spotless record.
1,800 cases of Wylwood Frozen Fresh Broccoli Cuts — produced by Congelados Co. — were recalled in spring 2016 due to a common contamination culprit: Listeria monocytogenes. Responsible for a range of symptoms from flu-like ailments to intestinal distress, Listeria can even survive refrigeration and freezing. Because it's so adaptable, no food — even brozen broccoli — is safe once exposed to this pesky bacteria.
The Ohio Department of Agriculture identified the bacteria in a routine test, causing the voluntary recall to be set in motion. Because the frozen broccoli was shipped across the country to nearly a dozen states, including Ohio, Georgia, North Carolina, and Indiana, it resulted in a widespread recall of the tainted veggie. Consumers were advised to toss any one-pound bags featuring a single UPC code in the trash to avoid potential exposure to unwanted food-borne illness. Luckily, no illnesses were identified in connection to this particular product.
In fall 2013, a different broccoli salad kit was the source of possible contamination. This Taylor Farms product included salad dressing that may have been compromised with Listeria monocytogenes, a bacteria that can make even healthy people extremely ill — and is especially dangerous for those who are immunocompromised.
Based in both Texas and Maryland, Taylor Farms had shipped the salad kits across the country to Maryland, Massachusetts, New Jersey, New York, Pennsylvania, Texas, and Virginia, recalling bags of the salad kit from all seven states. While making a broccoli salad with a pre-prepared kit is a fast and easy option, it's also equally delicious when made from scratch if you're looking for a way to vet all of the ingredients before consuming
Though no illnesses were linked to this case of contamination, Taylor Farms has unfortunately been the subject of multiple recalls in the years since. In 2018, the brand recalled a pork carnitas bowl featuring tomatillos possibly exposed to both salmonella and Listeria monocytogenes. In 2024, they recalled another salad kit; this time, nearly 20,000 pounds of apple walnut chicken salad bowls were flagged because of an undeclared wheat allergen.
Read the original article on Mashed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BioHub Maryland, Powered by the Maryland Tech Council, Partners with Bowie State University On Summer Life Sciences Training for Students
BioHub Maryland, Powered by the Maryland Tech Council, Partners with Bowie State University On Summer Life Sciences Training for Students

Business Wire

time26 minutes ago

  • Business Wire

BioHub Maryland, Powered by the Maryland Tech Council, Partners with Bowie State University On Summer Life Sciences Training for Students

ROCKVILLE, Md.--(BUSINESS WIRE)--In a move to expand pathways into Maryland's life sciences industry, BioHub Maryland, powered by Maryland Tech Council, and Bowie State University, the state's first historically Black College/University, are partnering to give two dozen undergraduates hands-on experience in biopharmaceutical manufacturing this summer. By working with Bowie State University, we're ensuring a more robust pipeline of talent is ready to lead the next generation of biotech breakthroughs—right here in Maryland. The partnership aims to equip students with the technical skills needed to fill in-demand jobs in one of Maryland's most innovative industries. Over four weeks, students from the university's Department of Natural Sciences receive immersive, lab-based training at the BioHub Maryland Training and Education Center in Rockville— an 8,200 square-foot facility replicating real-world biopharma production environments. 'BioHub Maryland doesn't just train students—it launches careers,' said Kelly Schulz, Chief Executive Officer of the Maryland Tech Council. 'By working with Bowie State University, we're ensuring a more robust pipeline of talent is ready to lead the next generation of biotech breakthroughs—right here in Maryland.' Students will learn core biopharma manufacturing skills such as upstream processing, cell culture, and quality control—all of which are essential to the production of vaccines and other treatments. Curricula is designed by the National Institute for Bioprocessing Research and Training (NIBRT), BioHub Maryland's globally-trusted training provider. Upon completion, each student will earn a certificate recognized by life sciences employers. Training takes place at the Rockville-based BioHub Maryland Training and Education Center at Montgomery County, a state-of-the-art facility made possible by Montgomery County and the State of Maryland. The partnership between BioHub Maryland and Bowie State University accelerates Maryland's life sciences leadership. Home to 2,700 life sciences companies and 54,000 life sciences workers, the state is part of the BioHealth Capital Region, recently ranked the #3 biopharma cluster in the U.S. Bowie State's Department of Natural Sciences Chair and Professor, Dr. George Ude, and Associate Professor, Dr. Supriyo Ray, secured this opportunity for their students through a National Institute of Standards & Technology (NIST) grant. About BioHub Maryland BioHub Maryland is accelerating the life sciences industry for companies and career seekers to expand the state's global innovation advantage. A workforce initiative of the Maryland Tech Council, the largest technology and life sciences trade association in the state, BioHub Maryland enables residents of all backgrounds to compete for rewarding careers in life sciences by offering skills training, career resources, and access to job openings. BioHub Maryland also helps life sciences companies at every stage grow by showcasing their career opportunities, training the next generation of life sciences talent, and providing strategic resources for raising capital. Learn more at and follow us on LinkedIn, Instagram, Facebook, and Twitter.

Porosome Therapeutics Announces Breakthrough Alzheimer's Discoveries
Porosome Therapeutics Announces Breakthrough Alzheimer's Discoveries

Business Wire

timean hour ago

  • Business Wire

Porosome Therapeutics Announces Breakthrough Alzheimer's Discoveries

BOSTON--(BUSINESS WIRE)-- Porosome Therapeutics, Inc. (Porosome Therapeutics) today announced key advancements in its first-in-class, disease-modifying neurological platform, which will transform Alzheimer's Disease (AD) research and treatment by offering a new approach that goes beyond symptom management. Following the recent FDA validation of organoid-based studies, the company has demonstrated a relatively rapid reduction of the Alzheimer's pathology in AD human brain organoids treated with its principal therapy; shown a significant reduction of the Tau protein, acknowledged by the Food and Drug Administration (FDA) as an AD biomarker, in other studies; and established new classes of AD therapeutics. Implementing the company's signature ' Reprogram, Restore, and Rescue ' strategy, researchers introduce healthy porosomes – neuronal secretory nanomachines – into diseased neurons to target the root causes of AD. By restoring the neuron's secretory and metabolic systems, Porosome Therapeutics' first-of-its-kind approach addresses the cellular function of AD rather than traditional symptom management. 'Unlike therapies that merely dissolve beta amyloid plaques, our platform directly targets the core biological dysfunctions of Alzheimer's, restoring both neurotransmission and metabolic integrity,' said Guillermo Marmol, CEO, Porosome Therapeutics. 'Given Alzheimer's is a serious and life-threatening disease with no effective treatment options, and based on our ability to deliver quantifiable, biomarker-driven improvements, including Tau reduction and disease reversal in human brain organoids, we are actively exploring the FDA's accelerated approval pathway.' In recent studies, the company's approach to porosome restoration has been shown to significantly reduce Tau protein levels – a key FDA-approved biomarker of Alzheimer's. The FDA's recent approval of the Tau test is a landmark development in the research for AD therapies, catalyzed by the groundbreaking science of Porosome Therapeutics. Furthermore, the company's therapeutic approach has been validated using FDA-recommended human brain organoid models, demonstrating fast clinical results with a significant reversal of Alzheimer's pathology shown within two weeks. Organoid models are three-dimensional cell cultures derived from stem cells that mimic the structure and function of human organs. 'When using human brain organoids, we're able to observe the molecular activity of the porosome at an entirely new scale,' said Bhanu P. Jena, PhD, Founder and Chairman, Porosome Therapeutics, and a distinguished cell biologist known for his discovery of the porosome nanomachine, the secretory portal of the cell. 'The ability to create an immense impact in just two weeks is a promising step forward and marks an important milestone as we advance the future of Alzheimer's research and care.' In a complementary development, the company is leveraging artificial intelligence (AI) to design proprietary decoy peptides that target and neutralize the toxic beta amyloid peptide (1-42), which is known for disrupting protein-protein interactions within the neuronal porosome complex and impairing neurotransmitter release. These specially designed AI-decoys bind more strongly to the beta amyloid (1-42), diverting the peptide from interfering with essential porosome functions. With these advances, Porosome Therapeutics has identified three distinct therapeutic classes for AD: Small Molecules and Peptides – Cross the blood-brain barrier to restore mitochondrial function. Biologics – Reconstitute the porosome complex to reverse neuronal secretory dysfunction. AI-Designed Peptides – Decoy peptides designed by AI to neutralize beta amyloid peptides (1-42) and protect neurotransmission. Porosome Therapeutics has expanded its portfolio of products to reflect these breakthroughs and the company's commitment to advancing novel treatment modalities beyond the current standard of care. About Porosome Therapeutics, Inc. Porosome Therapeutics, Inc. is a biopharmaceutical company based in Boston that leverages the groundbreaking discovery of the porosome — the cell's essential secretory machinery. The company employs innovative technologies to identify and develop proprietary therapeutics aimed at currently undruggable porosome proteins linked to secretory and hydration disorders such as cystic fibrosis, diabetes, and cancer. Porosome Therapeutics is the first company to employ a technology platform dedicated to creating novel therapies targeting the porosome, recognized as the universal secretory machinery in cells. This platform is built on decades of research and is supported by over 200 published studies, proving effective against various serious diseases involving secretory defects. The platform focuses on highly specific nanobody-mediated therapies, aiming to significantly reduce drug side effects. Porosome Therapeutics' work on Alzheimer's Disease is carried out through a subsidiary, NeuroTher LLC.

FDA Issues Update on Most Serious Recall for Certain Ventilators
FDA Issues Update on Most Serious Recall for Certain Ventilators

Epoch Times

timean hour ago

  • Epoch Times

FDA Issues Update on Most Serious Recall for Certain Ventilators

The Food and Drug Administration (FDA) issued a notice warning that medical ventilators made by Philips Respironics are still under a Class I recall due to the potential for serious injury or death. The agency noted that the recall notice for the company's V30, A30, and A40 ventilators, which are used for obstructive sleep apnea (OSA), primarily 'involves correcting devices and does not involve removing them from where they are used or sold.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store